Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.72
Delayed Data
As of Aug 30
 +0.46 / +3.01%
Today’s Change
6.91
Today|||52-Week Range
16.03
+68.85%
Year-to-Date
Vanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling
Aug 26 / TheStreet.com - Paid Partner Content
Vanda Pharmaceuticals (VNDA) Catches Eye: Stocks Up 20%
Aug 26 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for Vanda Pharmaceuticals (VNDA)?
Aug 26 / Zacks.com - Paid Partner Content
Why Tiffany, AEP Industries, and Vanda Pharmaceuticals Jumped Today
Aug 25 / MotleyFool.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
Aug 26 / Zacks.com - Paid Partner Content
Vanda Pharmaceuticals (VNDA) Stock Soars on Drug Patent Ruling
Aug 25 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close15.26
Today’s open15.32
Day’s range15.24 - 16.03
Volume1,008,712
Average volume (3 months)660,830
Market cap$660.5M
Dividend yield--
Data as of 3:59pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)-8.89%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...+0.06+0.33%
RPTPRaptor Pharmaceutica...+0.13+1.72%
INOInovio Pharmaceutica...+0.18+1.94%
ZIOPZIOPHARM Oncology In...-0.06-1.15%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

Search for Jobs